BCIwiki (bciwiki.com) — On August 9, 2026, six agencies in Fujian province in eastern China, the Department of Science and Technology, the Development and Reform Commission, the Department of Industry and Information Technology, the Health Commission, the Drug Administration and the Data Administration, jointly issued an action plan for the brain-computer interface technology industry for 2026 to 2030. Published on August 18 on the science department’s website, it made Fujian the 11th provincial-level region with a dedicated BCI policy.
The document is numbered Min Keshe [2026] No. 5 and covers 2026 to 2030.
By 2027 Fujian aims for breakthroughs in feature enhancement of evoked EEG signals, nonlinear neural decoding algorithms and high-resolution flexible electrodes, at least five innovative smaller firms, one cross-strait joint laboratory and two provincial innovation platforms, pilot use of BCIs in medical rehabilitation, and medical device registration of non-invasive products made in the province.
By 2030 it aims for a complete industry ecosystem, 30 innovative companies, a full chain from device fabrication, signal evocation, algorithm processing and feature enhancement to interactive applications, clinical breakthroughs for non-invasive products and technical breakthroughs in high-performance invasive electrode devices, and an industry exceeding RMB 3 billion.
Comparisons need matching years. Guangdong aims for 100 new technology companies and a core industry worth tens of billions of yuan by 2030. Zhejiang’s main companies already had revenue above RMB 2 billion in 2025, with a 2027 target of RMB 5 billion. Fujian’s RMB 3 billion is a 2030 figure.
The technical targets are specific. Key technologies center on evoked EEG feature enhancement and nonlinear decoding, and the 2027 registration target is limited to non-invasive products. Invasive technology appears only as a 2030 breakthrough in high-performance electrode devices, not as a product launch.
Geography is the plan’s distinctive element. It aims to make Fujian a cross-strait hub for BCI innovation cooperation and a national demonstration base for distinctive applications, and commits to a joint laboratory with Taiwanese research institutions and companies. Among provincial BCI policies issued so far, Fujian’s is the only one that includes cooperation with Taiwan.
Industry organization relies on the Fuzhou-Xiamen-Quanzhou National Independent Innovation Demonstration Zone, where a BCI technology industry alliance will be set up with guidance from the zone’s special funds. The plan gives no amounts, unlike Zhejiang or Shandong.
Products cover medical and industrial uses. On the rehabilitation side the plan names brain-controlled rehabilitation robots, limb rehabilitation training equipment, brain-controlled wheelchairs, BCI-assisted treatment systems and AR/VR postoperative rehabilitation equipment. On the industrial side it names brain-controlled remote manipulator arms, brain-controlled drone detection aids and BCI smart cockpits.
For clinical work, the plan supports universities and top-grade tertiary hospitals in building BCI clinical trial bases, research wards and pre-enrollment cohorts, and in improving clinical evaluation and ethics standards. A pre-enrollment cohort organizes eligible participants in advance so that trials can enroll faster once approved.
The provincial Data Administration is a co-issuer, as the data bureau is in Jiangsu. Neural data from BCIs requires a data regulator’s involvement in collection, storage and sharing.
Fujian’s existing work is in Fuzhou. In 2025 the city piloted a horse-race funding model for BCI, backing three teams in parallel on the same technical problem from integrative Chinese and Western medicine rehabilitation, artificial intelligence information processing and automated equipment. All three teams pair Fuzhou companies with universities and hospitals, and regular reviews decide which advance or merge.
No Fujian BCI service price items have been found. Who leads the cross-strait laboratory, which Taiwanese institutions take part and how much of the zone’s special funds go to BCI await implementation rules.